Curcumin Synergistically Enhances the Cytotoxicity of Arsenic Trioxide in U266 Cells by Increasing Arsenic Uptake

被引:6
|
作者
Han, Dingding [1 ]
Ma, Guibo [1 ]
Gao, Yujuan [1 ]
Su, Yanhua [1 ]
机构
[1] Harbin Med Univ, Hematol Dept, Affiliated Hosp 1, Harbin 150001, Peoples R China
关键词
HUMAN MULTIPLE-MYELOMA; INDUCED APOPTOSIS; SENSITIVITY; BORTEZOMIB; EXPRESSION; LEUKEMIA;
D O I
10.1155/2021/3083041
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Despite the constant emergence of new methods for the treatment of multiple myeloma (MM), relapse and drug resistance still exist, especially in MM with p53 mutations. Arsenic trioxide (ATO) can be used in MM treatment, but this single drug has poor effectiveness and also side effects. Curcumin is a safe and effective compound that can enhance the anticancer effects of many drugs. Previous studies have suggested that tumor cell sensitivity to ATO is related to the intracellular arsenic content, and aquaporin 9 (AQP9) is the key factor that determines intracellular arsenic content. This study aimed to explore whether curcumin can increase ATO cytotoxicity in MM and whether the mechanism is related to the regulation of intracellular arsenic content. U266 was treated with ATO, curcumin, and their combination, and cell proliferation, apoptosis, and intracellular arsenic content were detected by CCK-8 assay, flow cytometry, and HPLC-ICP-MS, respectively. AQP9 mRNA and protein levels were detected by qPCR and western blotting. The levels of Mcl-1, Bcl-2, Bax, caspase-3, and cleaved caspase-3 protein were detected by western blotting. ATO-induced cytotoxicity to U266 occurred in a time- and dose-dependent manner, but the therapeutic efficacy at low drug concentrations was modest. The arsenic content in U266 was lower than that in NB4, and the arsenic uptake by U266 was concentration-dependent. The expression levels of AQP9 mRNA and AQP9 protein in U266 were lower than those in NB4. Curcumin significantly enhanced the lethality of ATO to U266. The arsenic content in U266 in the combined drug group increased significantly compared with ATO treatment alone. After curcumin treatment, the AQP9 mRNA and AQP9 protein expression levels in U266 also increased. Compared with the control group, the expression of antiapoptotic proteins Mcl-1 and Bcl-2 decreased, the expression of proapoptotic protein Bax increased, the ratio of Bax/Bcl-2 increased, and the expression of caspase-3 decreased and cleaved caspase-3 increased in the combined drug groups. Curcumin can enhance the killing effects of ATO on U266 by increasing the intracellular arsenic content, which may be related to the upregulation of AQP9 expression. The combination of these two drugs is expected to be a potential clinical treatment for MM.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Pyrrolidine Dithiocarbamate Enhances the Cytotoxic Effect of Arsenic Trioxide on Acute Promyelocytic Leukemia Cells
    Yu, Simin
    Ge, Zhuowang
    Chen, Weixiang
    Han, Jinbin
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2023, 26 (11) : 2067 - 2076
  • [32] Dithiothreitol enhances arsenic trioxide-induced apoptosis in NB4 cells
    Gurr, JR
    Bau, DT
    Liu, F
    Lynn, S
    Jan, KY
    MOLECULAR PHARMACOLOGY, 1999, 56 (01) : 102 - 109
  • [33] Cucurbitacin B synergistically enhances the apoptosis-inducing effect of arsenic trioxide by inhibiting STAT3 phosphorylation in lymphoma Ramos cells
    Ding, Xiuli
    Chi, Jiadong
    Yang, Xue
    Hao, Jian
    Liu, Chang
    Zhu, Cuihong
    Wang, Xiaodong
    Liu, Xiaohui
    Niu, Yangyang
    Ji, Wei
    Chen, Dan
    Wu, Xiongzhi
    LEUKEMIA & LYMPHOMA, 2017, 58 (10) : 2439 - 2451
  • [34] Arsenic trioxide exposure to ovarian carcinoma cells leads to decreased level of topoisomerase II and cytotoxicity
    Askar, N.
    Cirpan, T.
    Toprak, E.
    Karabulut, B.
    Selvi, N.
    Terek, M. C.
    Uslu, R.
    Sanli, U. A.
    Goker, E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (04) : 1552 - 1556
  • [35] Melatonin enhances arsenic trioxide-induced cytotoxicity by modulating autophagy in an acute promyelocytic leukemia cell line
    Wei, Xia
    Pu, Xin
    Yang, Sainan
    Meng, Xiaoqin
    Chen, Xue
    Zhang, Zhihua
    Sheng, Xaomin
    Xiang, Dan
    Zhang, Yong
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (05) : 2079 - +
  • [36] MDM2 INHIBITION SYNERGISTICALLY ENHANCES CYTOTOXICITY OF MEK1 INHIBITOR AND ARSENIC TRIOXIDE (ATO) IN AML BLASTS THAT RETAIN A FUNCTIONAL P53 PATHWAY
    Mazzera, L.
    Lunghi, P.
    Mangoni, M.
    Caramatti, C.
    Rizzoli, V
    Bonati, A.
    HAEMATOLOGICA, 2008, 93 : S47 - S47
  • [37] Combination of arsenic trioxide and cisplatin synergistically inhibits both hexokinase activity and viability of Ehrlich ascites carcinoma cells
    Mansour, Mohammed A.
    Ibrahim, Wafaa M.
    Shalaan, Eman S.
    Salama, Afrah F.
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2019, 33 (08)
  • [38] Arsenic trioxide and proteasome inhibitor bortezomib synergistically induce apoptosis in leukemic cells:: the role of protein kinase Cδ
    Yan, H.
    Wang, Y.-C
    Li, D.
    Wang, Y.
    Liu, W.
    Wu, Y.-L
    Chen, G.-Q
    LEUKEMIA, 2007, 21 (07) : 1488 - 1495
  • [39] Arsenic trioxide and proteasome inhibitor bortezomib synergistically induce apoptosis in leukemic cells: the role of protein kinase Cδ
    H Yan
    Y-C Wang
    D Li
    Y Wang
    W Liu
    Y-L Wu
    G-Q Chen
    Leukemia, 2007, 21 : 1488 - 1495
  • [40] Arsenic Trioxide Synergistically Enhances the Antileukemia Activity of Bcl-2 Inhibitor ABT-199 in Acute Myeloid Leukemia
    Liu, Sha
    Chen, Lin
    Wang, Xiaojiao
    Mi, Ruihua
    Yin, Qingsong
    Fan, Ruihua
    Wei, Xudong
    BLOOD, 2019, 134